{
    "xml": "<topic id=\"PHP3315\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/flucloxacillin\" basename=\"flucloxacillin\" title=\"FLUCLOXACILLIN\">\n<title>FLUCLOXACILLIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_182\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/penicillins/flucloxacillin\">Flucloxacillin</xref>\n</p>\n<data name=\"vtmid\">96067005</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_642758992\" title=\"Penicillins (penicillinase-resistant)\">Penicillins (penicillinase-resistant)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34546\" title=\"PENICILLINS\" namespace=\"/drug-classes/penicillins\">PENICILLINS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP36399\" outputclass=\"indicationsAndDose\" rev=\"1.54\" parent=\"/drugs/flucloxacillin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Infections due to beta-lactamase-producing staphylococci including otitis externa</p>\n<p outputclass=\"therapeuticIndication\">Adjunct in pneumonia</p>\n<p outputclass=\"therapeuticIndication\">Adjunct in impetigo</p>\n<p outputclass=\"therapeuticIndication\">Adjunct in cellulitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>62.5&#8211;125&#8239;mg 4 times a day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;9 years</p>\n<p>125&#8211;250&#8239;mg 4 times a day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 10&#8211;17 years</p>\n<p>250&#8211;500&#8239;mg 4 times a day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>250&#8211;500&#8239;mg 4 times a day.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>250&#8211;500&#8239;mg every 6&#8239;hours.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.25&#8211;2&#8239;g every 6&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Endocarditis (in combination with other antibacterial if necessary)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 85 kg)</p>\n<p>8&#8239;g daily in 4 divided doses.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 85 kg and above)</p>\n<p>12&#8239;g daily in 6 divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Osteomyelitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Up to 8&#8239;g daily in 3&#8211;4 divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Surgical prophylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8211;2&#8239;g, to be administered up to 30 minutes before the procedure, then (by mouth or by intramuscular injection or by slow intravenous injection or by intravenous infusion) 500&#8239;mg every 6&#8239;hours if required for up to 4 further doses in high risk procedures.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Staphylococcal lung infection in cystic fibrosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>25&#8239;mg/kg 4 times a day (max. per dose 1&#8239;g), alternatively 100&#8239;mg/kg daily in 3 divided doses; maximum 4&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of <ph outputclass=\"organism\">\n<i>\n<i>Staphylococcus aureus</i>\n</i>\n</ph> lung infection in cystic fibrosis&#8212;primary prevention</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;3 years</p>\n<p>125&#8239;mg twice daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of <ph outputclass=\"organism\">\n<i>\n<i>Staphylococcus aureus</i>\n</i>\n</ph> lung infection in cystic fibrosis&#8212;secondary prevention</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>50&#8239;mg/kg twice daily (max. per dose 1&#8239;g twice daily).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36341\" outputclass=\"unlicensedUse\" rev=\"1.10\" parent=\"/drugs/flucloxacillin\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Flucloxacillin doses in the BNF may differ from those in product literature.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36431\" outputclass=\"importantSafetyInformation\" rev=\"1.11\" parent=\"/drugs/flucloxacillin\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Hepatic disorders</p>\n<p>Cholestatic jaundice and hepatitis may occur very rarely, up to two months after treatment with flucloxacillin has been stopped. Administration for more than 2 weeks and increasing age are risk factors. Healthcare professionals are reminded that:</p>\n<ul>\n<li>flucloxacillin should not be used in patients with a history of hepatic dysfunction associated with flucloxacillin</li>\n<li>flucloxacillin should be used with caution in patients with hepatic impairment</li>\n<li>careful enquiry should be made about hypersensitivity reactions to beta-lactam antibacterials</li>\n</ul>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36456\" outputclass=\"cautions\" rev=\"1.16\" parent=\"/drugs/flucloxacillin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"caution\">accumulation of electrolytes can occur with high doses</ph>; <ph outputclass=\"caution\">risk of kernicterus in jaundiced neonates when high doses given parenterally</ph> (in neonates)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36355\" outputclass=\"sideEffects\" rev=\"1.9\" parent=\"/drugs/flucloxacillin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gastrointestinal disturbances</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Cholestatic jaundice</ph>; <ph outputclass=\"sideEffect\">hepatitis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36382\" outputclass=\"pregnancy\" parent=\"/drugs/flucloxacillin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Not known to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36463\" outputclass=\"breastFeeding\" parent=\"/drugs/flucloxacillin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Trace amounts in milk, but appropriate to use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36420\" outputclass=\"hepaticImpairment\" parent=\"/drugs/flucloxacillin\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36363\" outputclass=\"renalImpairment\" parent=\"/drugs/flucloxacillin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Reduce dose if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Use normal dose every 8 hours if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Accumulation of electrolytes can occur in patients with renal failure.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36327\" outputclass=\"effectOnLaboratoryTests\" rev=\"1.8\" parent=\"/drugs/flucloxacillin\">\n<title>Effect on laboratory tests</title>\n<body>\n<section>\n<sectiondiv>\n<p>False-positive urinary glucose (if tested for reducing substances).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36471\" outputclass=\"directionsForAdministration\" rev=\"1.19\" parent=\"/drugs/flucloxacillin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous infusion</i>, dilute reconstituted solution <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9% and give intermittently over 30&#8211;60 minutes.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (<i>Floxapen</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%; suggested volume 100&#8239;mL given over 30&#8211;60 minutes.</p>\n<p>\n<i>via</i> drip tubing <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%; continuous infusion not usually recommended.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36374\" outputclass=\"patientAndCarerAdvice\" rev=\"1.12\" parent=\"/drugs/flucloxacillin\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Flucloxacillin for bacterial infections</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/flucloxacillin-for-bacterial-infections\">www.medicinesforchildren.org.uk/flucloxacillin-for-bacterial-infections</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP3315-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/flucloxacillin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: infusion</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76449\" title=\"Capsule\" namespace=\"/drugs/flucloxacillin/capsule\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76458\" title=\"Oral solution\" namespace=\"/drugs/flucloxacillin/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76454\" title=\"Powder for solution for injection\" namespace=\"/drugs/flucloxacillin/powder-for-solution-for-injection\">Powder for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78210\" namespace=\"/treatment-summaries/antibacterials-use-for-prophylaxis\" title=\"Antibacterials, use for prophylaxis\" count=\"4\" rel=\"backlink\">Antibacterials, use for prophylaxis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78284\" namespace=\"/treatment-summaries/skin-infections\" title=\"Skin infections\" count=\"1\" rel=\"backlink\">Skin infections</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78289\" namespace=\"/treatment-summaries/mrsa\" title=\"MRSA\" count=\"1\" rel=\"backlink\">MRSA</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78436\" namespace=\"/treatment-summaries/skin-infections-bacterial\" title=\"Skin infections, bacterial\" count=\"5\" rel=\"backlink\">Skin infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78449\" namespace=\"/treatment-summaries/ear-infections-bacterial\" title=\"Ear infections, bacterial\" count=\"1\" rel=\"backlink\">Ear infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78484\" namespace=\"/treatment-summaries/musculoskeletal-system-infections-bacterial\" title=\"Musculoskeletal system infections, bacterial\" count=\"2\" rel=\"backlink\">Musculoskeletal system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78502\" namespace=\"/treatment-summaries/penicillins\" title=\"Penicillins\" count=\"4\" rel=\"backlink\">Penicillins</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78577\" namespace=\"/treatment-summaries/respiratory-system-infections-bacterial\" title=\"Respiratory system infections, bacterial\" count=\"1\" rel=\"backlink\">Respiratory system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78592\" namespace=\"/treatment-summaries/cardiovascular-system-infections-bacterial\" title=\"Cardiovascular system infections, bacterial\" count=\"2\" rel=\"backlink\">Cardiovascular system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78609\" namespace=\"/treatment-summaries/ear\" title=\"Ear\" count=\"1\" rel=\"backlink\">Ear</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_182\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/penicillins/flucloxacillin\" title=\"Flucloxacillin\" count=\"1\" rel=\"link\">Flucloxacillin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34546\" namespace=\"/drug-classes/penicillins\" title=\"PENICILLINS\" count=\"1\" rel=\"link\">PENICILLINS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76449\" namespace=\"/drugs/flucloxacillin/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76458\" namespace=\"/drugs/flucloxacillin/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76454\" namespace=\"/drugs/flucloxacillin/powder-for-solution-for-injection\" title=\"Powder for solution for injection\" count=\"1\" rel=\"link\">Powder for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP3315",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/flucloxacillin",
    "basename": "flucloxacillin",
    "title": "FLUCLOXACILLIN",
    "interactants": [
        {
            "id": "bnf_int_182",
            "label": "Flucloxacillin"
        }
    ],
    "vtmid": "96067005",
    "drugClassification": [
        "Penicillins (penicillinase-resistant)"
    ],
    "inheritsFromClass": [
        "PENICILLINS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Infections due to beta-lactamase-producing staphylococci including otitis externa",
                        "html": "Infections due to beta-lactamase-producing staphylococci including otitis externa"
                    },
                    {
                        "textContent": "Adjunct in pneumonia",
                        "html": "Adjunct in pneumonia"
                    },
                    {
                        "textContent": "Adjunct in impetigo",
                        "html": "Adjunct in impetigo"
                    },
                    {
                        "textContent": "Adjunct in cellulitis",
                        "html": "Adjunct in cellulitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By slow intravenous injection or by intravenous infusion",
                    "html": "By slow intravenous injection or by intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "62.5&#8211;125 mg 4 times a day.",
                        "html": "<p>62.5&#8211;125&#8239;mg 4 times a day.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "125&#8211;250 mg 4 times a day.",
                        "html": "<p>125&#8211;250&#8239;mg 4 times a day.</p>",
                        "ageGroup": "2&#8211;9 years"
                    },
                    {
                        "textContent": "250&#8211;500 mg 4 times a day.",
                        "html": "<p>250&#8211;500&#8239;mg 4 times a day.</p>",
                        "ageGroup": "10&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "250&#8211;500 mg 4 times a day.",
                        "html": "<p>250&#8211;500&#8239;mg 4 times a day.</p>"
                    },
                    {
                        "textContent": "250&#8211;500 mg every 6 hours.",
                        "html": "<p>250&#8211;500&#8239;mg every 6&#8239;hours.</p>"
                    },
                    {
                        "textContent": "0.25&#8211;2 g every 6 hours.",
                        "html": "<p>0.25&#8211;2&#8239;g every 6&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Endocarditis (in combination with other antibacterial if necessary)",
                        "html": "Endocarditis (in combination with other antibacterial if necessary)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By slow intravenous injection or by intravenous infusion",
                    "html": "By slow intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "8 g daily in 4 divided doses.",
                        "html": "<p>8&#8239;g daily in 4 divided doses.</p>",
                        "ageGroup": "(body-weight up to 85 kg)"
                    },
                    {
                        "textContent": "12 g daily in 6 divided doses.",
                        "html": "<p>12&#8239;g daily in 6 divided doses.</p>",
                        "ageGroup": "(body-weight 85 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Osteomyelitis",
                        "html": "Osteomyelitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By slow intravenous injection or by intravenous infusion",
                    "html": "By slow intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Up to 8 g daily in 3&#8211;4 divided doses.",
                        "html": "<p>Up to 8&#8239;g daily in 3&#8211;4 divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Surgical prophylaxis",
                        "html": "Surgical prophylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "Initially by slow intravenous injection or by intravenous infusion",
                    "html": "Initially by slow intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "1&#8211;2 g, to be administered up to 30 minutes before the procedure, then (by mouth or by intramuscular injection or by slow intravenous injection or by intravenous infusion) 500 mg every 6 hours if required for up to 4 further doses in high risk procedures.",
                        "html": "<p>1&#8211;2&#8239;g, to be administered up to 30 minutes before the procedure, then (by mouth or by intramuscular injection or by slow intravenous injection or by intravenous infusion) 500&#8239;mg every 6&#8239;hours if required for up to 4 further doses in high risk procedures.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Staphylococcal lung infection in cystic fibrosis",
                        "html": "Staphylococcal lung infection in cystic fibrosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "25 mg/kg 4 times a day (max. per dose 1 g), alternatively 100 mg/kg daily in 3 divided doses; maximum 4 g per day.",
                        "html": "<p>25&#8239;mg/kg 4 times a day (max. per dose 1&#8239;g), alternatively 100&#8239;mg/kg daily in 3 divided doses; maximum 4&#8239;g per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of Staphylococcus aureus lung infection in cystic fibrosis&#8212;primary prevention",
                        "html": "Prevention of <ph outputclass=\"organism\"> <i> <i>Staphylococcus aureus</i> </i> </ph> lung infection in cystic fibrosis&#8212;primary prevention",
                        "organism": "Staphylococcus aureus"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "Staphylococcus aureus"
                },
                "child": [
                    {
                        "textContent": "125 mg twice daily.",
                        "html": "<p>125&#8239;mg twice daily.</p>",
                        "ageGroup": "1 month&#8211;3 years"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of Staphylococcus aureus lung infection in cystic fibrosis&#8212;secondary prevention",
                        "html": "Prevention of <ph outputclass=\"organism\"> <i> <i>Staphylococcus aureus</i> </i> </ph> lung infection in cystic fibrosis&#8212;secondary prevention",
                        "organism": "Staphylococcus aureus"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "Staphylococcus aureus"
                },
                "child": [
                    {
                        "textContent": "50 mg/kg twice daily (max. per dose 1 g twice daily).",
                        "html": "<p>50&#8239;mg/kg twice daily (max. per dose 1&#8239;g twice daily).</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Flucloxacillin doses in the BNF may differ from those in product literature.",
                "html": "<p>Flucloxacillin doses in the BNF may differ from those in product literature.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "title": "Hepatic disorders",
                "textContent": "Cholestatic jaundice and hepatitis may occur very rarely, up to two months after treatment with flucloxacillin has been stopped. Administration for more than 2 weeks and increasing age are risk factors. Healthcare professionals are reminded that:\n\nflucloxacillin should not be used in patients with a history of hepatic dysfunction associated with flucloxacillin flucloxacillin should be used with caution in patients with hepatic impairment careful enquiry should be made about hypersensitivity reactions to beta-lactam antibacterials",
                "html": "<p>Cholestatic jaundice and hepatitis may occur very rarely, up to two months after treatment with flucloxacillin has been stopped. Administration for more than 2 weeks and increasing age are risk factors. Healthcare professionals are reminded that:</p><ul>\n<li>flucloxacillin should not be used in patients with a history of hepatic dysfunction associated with flucloxacillin</li>\n<li>flucloxacillin should be used with caution in patients with hepatic impairment</li>\n<li>careful enquiry should be made about hypersensitivity reactions to beta-lactam antibacterials</li>\n</ul>"
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "accumulation of electrolytes can occur with high doses",
                "html": "accumulation of electrolytes can occur with high doses",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "risk of kernicterus in jaundiced neonates when high doses given parenterally in neonates",
                "html": "risk of kernicterus in jaundiced neonates when high doses given parenterally in neonates",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ],
                    "patientType": "neonates"
                }
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Gastrointestinal disturbances",
                        "html": "Gastrointestinal disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Cholestatic jaundice",
                        "html": "Cholestatic jaundice",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hepatitis",
                        "html": "hepatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Not known to be harmful.",
                "html": "<p>Not known to be harmful.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Trace amounts in milk, but appropriate to use.",
                "html": "<p>Trace amounts in milk, but appropriate to use.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Reduce dose if eGFR less than 10 mL/minute/1.73 m2.",
                "html": "<p>Reduce dose if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Use normal dose every 8 hours if estimated glomerular filtration rate less than 10 mL/minute/1.73 m2.",
                "html": "<p>Use normal dose every 8 hours if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Accumulation of electrolytes can occur in patients with renal failure.",
                "html": "<p>Accumulation of electrolytes can occur in patients with renal failure.</p>"
            }
        ]
    },
    "effectOnLaboratoryTests": {
        "effectOnLaboratoryTests": [
            {
                "type": "effectOnLaboratoryTests",
                "textContent": "False-positive urinary glucose (if tested for reducing substances).",
                "html": "<p>False-positive urinary glucose (if tested for reducing substances).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion, dilute reconstituted solution in Glucose 5% or Sodium Chloride 0.9% and give intermittently over 30&#8211;60 minutes.",
                "html": "<p>For <i>intravenous infusion</i>, dilute reconstituted solution <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9% and give intermittently over 30&#8211;60 minutes.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Floxapen ), give intermittently in Glucose 5% or Sodium chloride 0.9%; suggested volume 100 mL given over 30&#8211;60 minutes.\n\nvia drip tubing in Glucose 5% or Sodium chloride 0.9%; continuous infusion not usually recommended.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Floxapen</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%; suggested volume 100&#8239;mL given over 30&#8211;60 minutes.</p><p>\n<i>via</i> drip tubing <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%; continuous infusion not usually recommended.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/flucloxacillin-for-bacterial-infections",
                        "label": "www.medicinesforchildren.org.uk/flucloxacillin-for-bacterial-infections"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Flucloxacillin for bacterial infections",
                "textContent": "www.medicinesforchildren.org.uk/flucloxacillin-for-bacterial-infections",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/flucloxacillin-for-bacterial-infections\">www.medicinesforchildren.org.uk/flucloxacillin-for-bacterial-infections</xref>\n</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "infusion"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76449",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76458",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76454",
                "label": "Powder for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78210",
                "label": "Antibacterials, use for prophylaxis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78284",
                "label": "Skin infections",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78289",
                "label": "MRSA",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78436",
                "label": "Skin infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78449",
                "label": "Ear infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78484",
                "label": "Musculoskeletal system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78502",
                "label": "Penicillins",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78577",
                "label": "Respiratory system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78592",
                "label": "Cardiovascular system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78609",
                "label": "Ear",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_182",
                "label": "Flucloxacillin",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34546",
                "label": "PENICILLINS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76449",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76458",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76454",
                "label": "Powder for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}